Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and ...

A Class II recall, as defined by the FDA, is for item that "may cause temporary or medically reversible adverse health consequences." No press release was issued concerning the recall by Sun ...

Attention-deficit/hyperactivity disorder has long been treated mainly with stimulants, and the handful of non-stimulant ...

Add Yahoo as a preferred source to see more of our stories on Google. Sun Pharmaceutical Industries has recalled multiple lots of lisdexamfetamine dimesylate capsules, the generic version of the ADHD ...

Methylphenidate helps the brain to regulate focus and impulse control. It is the most commonly used medicine for ADHD and is the active substance in Concerta, Ritalin, Medikinet and other medicines.

Stimulants like methylphenidate (Ritalin, Concerta, and others) are the most commonly prescribed ADHD medications for children. They work by increasing brain chemicals such as dopamine and ...

Researchers in the UK found no evidence that methylphenidate, the active ingredient in Ritalin, increases children's odds of later developing schizophrenia. Reading time 3 minutes No drug comes ...